恶性胸膜间皮瘤的化疗 - Suppr

Suppr

超能文献

Chemotherapy for malignant pleural mesothelioma.

作者信息

Vogelzang Nicholas J

机构信息

Nevada Cancer Institute, Las Vegas, Nevada 89135, USA.

出版信息

Lancet. 2008 May 17;371(9625):1640-2. doi: 10.1016/S0140-6736(08)60703-5.

DOI:10.1016/S0140-6736(08)60703-5

PMID:18486725

Abstract

摘要

相似文献

Chemotherapy for malignant pleural mesothelioma.

Lancet. 2008 May 17;371(9625):1640-2. doi: 10.1016/S0140-6736(08)60703-5.

[Chemotherapy of malignant pleural mesothelioma: have we made any progress?].

Zentralbl Chir. 2008 Jun;133(3):238-42. doi: 10.1055/s-2008-1004809.

Pemetrexed and cisplatin for malignant pleural mesothelioma: a new standard of care?

J Clin Oncol. 2003 Jul 15;21(14):2629-30. doi: 10.1200/JCO.2003.02.043.

The new front line treatment for malignant pleural mesothelioma?

Thorax. 2003 Feb;58(2):96-7. doi: 10.1136/thorax.58.2.96.

Chemotherapy of malignant pleural mesothelioma.

Expert Opin Pharmacother. 2009 Jan;10(1):99-107. doi: 10.1517/14656560802631285.

Systemic drug therapy of malignant pleural mesothelioma.

Monaldi Arch Chest Dis. 1998 Apr;53(2):236-40.

Trials in malignant mesothelioma. LCSG 851 and 882.

Chest. 1994 Dec;106(6 Suppl):359S-362S.

Current options for systemic therapy in mesothelioma.

Semin Thorac Cardiovasc Surg. 2009 Summer;21(2):154-8. doi: 10.1053/j.semtcvs.2009.06.010.

Thoracic stop-flow perfusion in the treatment of refractory malignant pleural mesothelioma: a phase I-II evaluation/trial.

In Vivo. 2006 Nov-Dec;20(6A):715-8.

Second-line chemotherapy in malignant pleural mesothelioma: results of a retrospective multicenter survey.

Lung Cancer. 2012 Mar;75(3):360-7. doi: 10.1016/j.lungcan.2011.08.011. Epub 2011 Sep 19.

引用本文的文献

Quality of Life Is Not Deteriorated After Extrapleural Pneumonectomy vs. (Extended) Pleurectomy/Decortication in Patients With Malignant Pleural Mesothelioma.

Front Surg. 2021 Dec 8;8:766033. doi: 10.3389/fsurg.2021.766033. eCollection 2021.

Isolated thoracic perfusion with chemofiltration for progressive malignant pleural mesothelioma.

Onco Targets Ther. 2017 Jun 19;10:3049-3057. doi: 10.2147/OTT.S134126. eCollection 2017.

Novel systemic therapy against malignant pleural mesothelioma.

Transl Lung Cancer Res. 2017 Jun;6(3):295-314. doi: 10.21037/tlcr.2017.06.01.

Novel oncolytic viral therapies in patients with thoracic malignancies.

Oncolytic Virother. 2016 Dec 21;6:1-9. doi: 10.2147/OV.S116012. eCollection 2017.

Progranulin and granulin-like protein as novel VEGF-independent angiogenic factors derived from human mesothelioma cells.

Oncogene. 2017 Feb 2;36(5):714-722. doi: 10.1038/onc.2016.226. Epub 2016 Jun 27.

A proteomics-based approach identifies secreted protein acidic and rich in cysteine as a prognostic biomarker in malignant pleural mesothelioma.

Br J Cancer. 2016 Mar 1;114(5):524-31. doi: 10.1038/bjc.2015.470. Epub 2016 Feb 18.

The role of interleukin-6 in malignant mesothelioma.

Transl Lung Cancer Res. 2015 Feb;4(1):55-66. doi: 10.3978/j.issn.2218-6751.2014.07.01.

Serum concentration of integrin-linked kinase in malignant pleural mesothelioma and after asbestos exposure.

Eur J Cardiothorac Surg. 2013 May;43(5):940-5. doi: 10.1093/ejcts/ezs521. Epub 2012 Oct 7.

Oncolytic measles viruses encoding interferon beta and the thyroidal sodium iodide symporter gene for mesothelioma virotherapy.

Cancer Gene Ther. 2010 Aug;17(8):550-8. doi: 10.1038/cgt.2010.10. Epub 2010 Apr 9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验